Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma
Abstract The emergence of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Biomarkers of the therapeutic efficacy of ICIs have been extensively investigated. In this study, we aimed to analyze whether mo...
Guardado en:
Autores principales: | Hiroe Tada, Hideyuki Takahashi, Reika Kawabata-Iwakawa, Yurino Nagata, Miho Uchida, Masato Shino, Shota Ida, Ikko Mito, Toshiyuki Matsuyama, Kazuaki Chikamatsu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b28b2d63a4804c69a542aee6503715fb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma
por: Ikko Mito, et al.
Publicado: (2021) -
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma
por: Hideyuki Takahashi, et al.
Publicado: (2021) -
Diffuse large B-cell lymphoma of the pterygopalatine fossa with multiple cranial nerve palsies
por: Shota Ida, et al.
Publicado: (2021) -
Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab
por: Kiyoshi Minohara, et al.
Publicado: (2021) -
IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses
por: Taylor A. Harper, et al.
Publicado: (2021)